Skip to content
healthcare.dev

Excedrin PM Triple Action Caplets

NDC 0067-2056, Acetaminophen, Aspirin (NSAID) and Diphenhydramine Citrate, tablet, coated, from Haleon US Holdings LLC.

Product NDC
0067-2056
Status
Listed
Labeler
Haleon US Holdings LLC
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0067-2056 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAMINOPHEN250 mg/1
  • ASPIRIN250 mg/1
  • DIPHENHYDRAMINE CITRATE38 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]

Package NDCNDC-11Package
0067-2056-24000672056241 BOTTLE in 1 CARTON (0067-2056-24) / 24 TABLET, COATED in 1 BOTTLE
0067-2056-91000672056911 BOTTLE in 1 CARTON (0067-2056-91) / 100 TABLET, COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0067-2056 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0067-2056 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0067-2056. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.